Monte Rosa Therapeutics, Inc.
$14.31
+0.37 (+2.65%)
Price as of Sep 01, 2026 market close
Performance
- 1 Month
- -7.0%
- 3 Months
- -19.3%
- YTD
- -8.7%
- 1 Year
- +198.1%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 96.6%
- Largest decline max drawdown, since Aug 2025
- -47.1%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.57
Own GLUE?
See how GLUE contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.